PUMA BIOTECHNOLOGY INC (PBYI) Stock Balance Sheet
NASDAQ:PBYI • US74587V1070
Current stock price
6.12 USD
-0.03 (-0.49%)
At close:
6.12 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.64M | 69.22M | 84.58M | 76.20M | 63.10M | |||
| Marketable Securities | 67.89M | 31.75M | 11.35M | 4.90M | 19.00M | |||
| Receivables | 53.65M | 32.01M | 47.84M | 42.30M | 32.50M | |||
| Inventories | 5.51M | 8.72M | 7.08M | 4.50M | 7.10M | |||
| Other Current Assets | 5.99M | 5.96M | 5.33M | 6.40M | 18.30M | |||
| Total Current Assets | 162.69M | 147.66M | 156.19M | 134.30M | 140.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.56M | 5.09M | 8.65M | 12.50M | 15.80M | |||
| Intangibles | 41.39M | 51.13M | 60.87M | 70.60M | 66.10M | |||
| Other Non-Current Assets | 6.66M | 9.45M | 4.83M | 4.70M | 4.70M | |||
| Total Non-Current Assets | 53.62M | 65.67M | 74.34M | 87.80M | 86.60M | |||
| TOTAL ASSETS | 216.30M | 213.33M | 230.53M | 222.10M | 226.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 22.52M | 45.33M | 34.00M | N/A | 0.00 | |||
| Accrued Expenses | 51.34M | 42.44M | 57.52M | 69.70M | 96.10M | |||
| Accounts Payable | 5.06M | 5.51M | 6.89M | 6.40M | 11.20M | |||
| Other Current Liabilities | 2.33M | 2.83M | 975.00K | 1.40M | 2.30M | |||
| Total Current Liabilities | 81.25M | 96.11M | 99.38M | 77.50M | 109.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 21.72M | 65.66M | 98.30M | 97.10M | |||
| Other Non-Current Liabilities | 4.71M | 3.38M | 12.04M | 24.70M | 22.40M | |||
| Total Non-Current Liabilities | 4.71M | 25.10M | 77.70M | 123.00M | 119.40M | |||
| TOTAL LIABILITIES | 85.96M | 121.21M | 177.09M | 200.50M | 229.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.28B | -1.31B | -1.35B | -1.37B | -1.37B | |||
| Additional Paid In Capital | 1.41B | 1.41B | 1.40B | 1.39B | 1.36B | |||
| Common Shares | 5.00K | 5.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 36.00K | 6.00K | -4.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 50.41M | 49.11M | 47.65M | 46.30M | 41.20M | |||
| Tangible Book Value per Share | 1.76 | 0.83 | -0.16 | -1.06 | -1.66 | |||
| Total Shareholders' Equity | 130.34M | 92.13M | 53.44M | 21.60M | -2.40M | |||
| TOTAL LIABILITIES AND EQUITY | 216.30M | 213.33M | 230.53M | 222.10M | 226.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.24 | 1.23 | 4.55 | -40.46 | |||
| Current Ratio | 2.00 | 1.54 | 1.57 | 1.73 | 1.28 | |||
| Return On Assets (ROA) | 14.38% | 14.19% | 9.37% | N/A | -12.84% | |||
| Return On Equity (ROE) | 23.87% | 32.87% | 40.40% | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 24.01% | 22.97% | 22.05% | 14.31% | 0.97% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 86.43% | 165.61% | 82.15% | 32.59% | 3.24% | |||
All data in USD , ROIC based on taxRate of 0.13